Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors

Background: Cardiovascular adverse events (CV-AEs) are considered critical complications in chronic myeloid leukemia (CML) patients treated with second- and third-generation tyrosine kinase inhibitors (TKIs). The aim of our study was to assess the correlation between metabolic profiles and CV-AEs in...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Med
Auteurs principaux: Caocci, Giovanni, Deidda, Martino, Noto, Antonio, Greco, Marianna, Simula, Maria Pina, Mulas, Olga, Cocco, Daniele, Fattuoni, Claudia, Mercuro, Giuseppe, La Nasa, Giorgio, Cadeddu Dessalvi, Christian
Format: Artigo
Langue:Inglês
Publié: MDPI 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7231160/
https://ncbi.nlm.nih.gov/pubmed/32326001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9041180
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires